Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Inhibition of HRP-3 using modified oligonucleotides
Method and apparatus for map transmission in wireless communication system
Detecting the type of NAT firewall using messages
System and method for providing radio communication in a land mobile radio system
Identification of electrical grid phase information for end-points in a grid network
Equipment to facilitate money transfers into bank accounts
Metal melting apparatus and method for melting metal
  Randomly Featured Patents
Pressure testing device for vehicle radiators and cooling systems
Hibiscus rosa-sinensis plant named `Snowfire`
Stereo image display device
2'-Substituted-spiro[benzofuran-2(3H),1'-cyclohexanes] and its pharmaceutical use
Window component extrusion
Method of communication between firmware written for different instruction set architectures
Fast FLASH EPROM programming and pre-programming circuit design
Method and apparatus for unified communication management via instant messaging
Light fixture
Method of inspecting piezoelectric ceramic device